Product
Supplier
Encyclopedia
Inquiry
Home > Pharmaceutical Intermediates > Bulk Drug Intermediates > Setipiprant for Sale > Hair loss treatment Setipiprant, SETIPIPRANT 99% white powder 866460-33-5 Senwayer
Hair loss treatment Setipiprant, SETIPIPRANT 99% white powder  866460-33-5 Senwayer buy - large image1
Hair loss treatment Setipiprant, SETIPIPRANT 99% white powder  866460-33-5 Senwayer buy - image1
Hair loss treatment Setipiprant, SETIPIPRANT 99% white powder  866460-33-5 Senwayer buy - image2

Hair loss treatment Setipiprant, SETIPIPRANT 99% white powder 866460-33-5 Senwayer

Unit Price: Get Latest Price
CAS No.:

866460-33-5

Grade:

Pharmaceutical Grade

Content:

99%

Port:

shanghai

Brand:

Senwayer

Packaging:

bag

Price valid (until):

2023-05-12

Company Type:
Trader
Location:
China
Payment Terms:
TT against copy of documents,L/C
Average Lead Time:
10 days
Qualification:
Main Products:

API,nutrition supplements,plant extract,peptide,HCG,6-Aminocaproic acid

  • Product Description

  • Seller Information

  • Description


      Product Introduction  


    Setipipran is an oral drug that’s currently being tested for use as a hair loss treatment. It was initially developed as a treatment for allergic rhinitis, but recent hair loss-related discoveries have made it a better candidate for hair loss reversal.


    Product nameSetipiprant
    CAS No.866460-33-5
    MFC24H19FN2O3
    MW402.42
    Boiling point690.4±55.0 °C(Predicted)
    Density1.37±0.1 g/cm3(Predicted)





      Product Uses  


    For Allergies/Asthma

    As setipiprant is believed to interfere with the receptors known to contribute to allergies/allergic responses, the drug was first tested on allergies and asthma.

    In clinical trials, the drug performed quite well in the treatment of allergen-induced airway responses in asthmatic patients. It was also well tolerated by participants. However, its results were similar to those of drugs already on the market, so further trials were discontinued.

    For Hair Loss

    In 2012, researchers discovered a link between the PGD2 receptor and hair loss. More specifically, this receptor is seen at high levels in the scalps of men diagnosed with Androgenetic Alopecia (AGA).

    AGA (Male-Pattern Baldness) is the most common cause of hair loss in men, though it’s also seen in women (Female Pattern Hair Loss). It’s believed to be caused by a sensitivity to DHT, which is an androgen hormone that attaches to the follicles and leads to inflammation and irritation.


     

    Setipiprant vs. Finasteride

      


    There’s no doubt that setipiprant and finasteride have a similar end game, and that’s to prevent hair loss. But how different are their mechanisms, and which is better?

    If you think of the hair loss process as a timeline, then finasteride interferes much sooner in the process. That is, it inhibits the expression of 5-alpha-reductase (5AR), which is responsible for the production of DHT. In this way, less androgen receptors are activated on the scalp and PGD2 production is slowed or even ceased.

    Setipiprant, though, enables 5AR to create DHT, and the process continues until PGD2 comes into play. It is then that the drug interferes, preventing PGD2 receptors from being activating (which is, essentially, the final step).


      Product Side Effects  


    While the full effects of setipiprant on hair loss are still unknown, previous studies have shed some light on possible adverse effects.

    The studies which were focused on setipiprant as a treatment for allergic rhinitis and asthma saw side effects, such as:

    • Dry mouth
    • Nausea
    • Drowsiness
    • Elevation of liver enzymes
    • Anxiety

    In one patient, cholelithiasis (gallstones) developed during the time of the trial. This could very well be directly related to setipiprant (as it’s been shown to effect liver enzymes).


      About us  


    Wuhan senwayer century chemical Co.,Ltd located in the predominant WuHan City where is a traffic hinge of China,specilize in producing and developing pharmaceutical & its intermediates, Pesticide Intermediate, food additive, Plant extracts,and in distributing the products of our own company and affiliated enterprises.

    We have set up R&D center, quality inspection center and manufacturing site in Wuhan, Jiangsu and others places.
    Our company has professional staff who deal with chemical R&D and scientific management, and holds several sets of analyzing instruments with high efficiency and high sensitivity, such as HPLC, GC and Spectrophotometer. Meanwhile, we possess of complete Q.A. and Q.C. system, supply chemical products with good quality and custom-tailored products according to our clients' requirement.
    We have professional sales team, focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market , our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.

    With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers.

    If you are interested, pls contact me freely!

    ECHEMI Editorial Reference
    Setipiprant is an orally available, selective CRTH2 antagonist. CRTH2 is a G protein-coupled receptor for PGD2.IC50 value: 6.0 nMTarget: PGD2in vitro: Setipiprant is an orally available, selective CRTH2 (chemoattractant receptor-homologous molecule expressed on T helper [Th]-2 cells) antagonist. CRTH2 is a G protein-coupled receptor for prostaglandin (PGD2). PGD2 is produced by the mast cells and is a key mediator in various inflammatory diseases, including allergy and asthma. Binding of
    Setipiprant is a naphthalenecarboxamide.|Setipiprant has been investigated for the treatment of Seasonal Allergic Rhinitis.

    Basic Info
    Product Name:

    Setipiprant

    Other Name:

    5H-Pyrido[4,3-b]indole-5-acetic acid,8-fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-;8-Fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-5H-pyrido[4,3-b]indole-5-acetic acid;Setipiprant;ACT 129968;2-(2-(1-Naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid;1263765-62-3

    CAS No.:

    866460-33-5

    Molecular Formula:

    C24H19FN2O3

    InChIKeys:

    InChIKey=IHAXLPDVOWLUOS-UHFFFAOYSA-N

    Molecular Weight:

    402.425

    Exact Mass:

    402.42

    UNII:

    BHF20LA2GM

    DSSTox ID:

    DTXSID00235739

    Characteristics
    PSA:

    62.5

    XLogP3:

    3.39

    Appearance:

    Light yellow to yellow solid

    Density:

    1.4±0.1 g/cm3

    Boiling Point:

    690.4±55.0 °C at 760 mmHg

    Flash Point:

    371.4±31.5 °C

    Refractive Index:

    1.682

    Hazard Identification

    Classification of the substance or mixture

    no data available

    GHS label elements, including precautionary statements

    Pictogram(s) no data available
    Signal word

    no data available

    Hazard statement(s)

    no data available

    Precautionary statement(s)
    Prevention

    no data available

    Response

    no data available

    Storage

    no data available

    Disposal

    no data available

    Other hazards which do not result in classification

    no data available

    Handling and Storage

    Precautions for safe handling

    Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

    Conditions for safe storage, including any incompatibilities

    Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    API,nutrition supplements,plant extract,peptide,HCG,6-Aminocaproic acid

    Location:

    Room 707, Block A, Zhongxing Times Digital Trade Port, No. 79 Xudong Street, Hongshan District, Wuhan City

    Payment Terms:

    TT against copy of documents,L/C

    Average lead Time:

    10 days

    Total Annual Revenue:

    $2.5 million-$5 million

    Total Employees:

    51-100

    Year of Establishment:

    2020

    Company Certificates
    • Dingwang Technology (Wuhan) Co., Ltd.Verified supplier certificate Verified supplier certificate
    • Dingwang Technology (Wuhan) Co., Ltd.SGS SGS
      Dingwang Technology (Wuhan) Co., Ltd located in the predominant WuHan City where is a traffic hinge of China,specilize in producing and developing pharmaceutical & its intermediates, Peptide, Nutritional supplements,food additive, Plant extracts,and in distributing the products of our own company and affiliated enterprises.
          We have set up R&D center, quality inspection center and manufacturing site in Wuhan, Jiangsu and others places.

    Our company has professional staff who deal with chemical R&D and scientific management, and holds several sets of analyzing instruments with high efficiency and high sensitivity, such as HPLC, GC and Spectrophotometer. Meanwhile, we possess of complete Q.A. and Q.C. system, supply chemical products with good quality and custom-tailored products according to our clients' requirement.
           We have professional sales team, focus on quality and service, and we have achieved excellent performance over the years. Our company is committed to the development of international market , our products are mainly exported to many countries and regions, such as Europe, America, South-east Asia, the Middle East and Africa etc.
         With our constant efforts and good service, We sincerely hope to establish long-term cooperation and common development with our customers.
  • Country Product Purchase Quantity Date Posted
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.